Genicular Artery Embolisation: A Breakthrough for Knee Osteoarthritis Patients

Researchers in Germany have discovered a minimally invasive treatment that offers lasting relief for knee osteoarthritis sufferers, potentially benefiting millions worldwide

Knee osteoarthritis, the most common form of arthritis, affects millions of people worldwide, causing chronic pain, inflammation, and reduced mobility. Traditional treatments range from lifestyle changes and medications to invasive surgeries, but a new study from Charite University Medicine Berlin offers hope through a minimally invasive alternative.

The study, published in the journal Radiologyexplores the effectiveness of genicular artery embolisation (GAE)a procedure that targets abnormal blood vessels around the joints. This innovative approach has shown promising results in reducing pain and improving quality of life for patients who have not responded well to conventional therapies.

Understanding the GAE Procedure

The GAE procedure involves a radiologist guiding a thin tube into the abnormal blood vessels around the knee joint. Tiny gelatin-based particles are then injected to block these vessels, reducing inflammation and alleviating pain. These particles dissolve within hours, making the treatment both safe and effective.

Florian Fleckenstein, deputy head of interventional radiology at Charite University Medicine Berlin and the study’s lead author, explains that GAE with resorbable microspheres may be the first procedure to alter the course of the disease, potentially slowing its progression. This breakthrough could fill a significant treatment gap for patients who find conservative measures insufficient but are not yet candidates for joint replacement.

The Study: Real-World Data and Significant Improvements

The study involved 194 participants with osteoarthritis-related knee pain, including 114 women and 80 men, with an average age of 69 and an average BMI of 28.4. All participants had previously failed to respond to at least three months of traditional treatment. Between July and, each participant underwent at least one GAE procedure, with 45 patients receiving two.

The results were remarkable. Participants rated their pain at seven out of 10 before treatment, which dropped to four out of 10 after six weeks. At both the six and 12-month follow-ups, average pain scores had fallen further to just three out of 10. Additionally, patients reported significant improvements in mobility, pain threshold, and day-to-day function.

Enhanced Quality of Life

Over the 12 months of treatment, patients experienced a greater ability to participate in sports and recreation. Their quality of life scores more than doubled, highlighting the profound impact of the GAE procedure. Dr. Fleckenstein emphasized that the results carry real weight because they come from real-world data, making it the largest body of evidence yet to support GAE for future treatments.

Most importantly, the study found that GAE provided significant, lasting pain relief and drastically improved mobility and function for patients with knee osteoarthritis. This could be a game-changer for the estimated 5.4 million people in the UK and more than 365 million worldwide who suffer from this debilitating condition.

The Future of Knee Osteoarthritis Treatment

Dr. Fleckenstein concluded that for the right patient, GAE can mean lasting relief from a single, minimally invasive procedure. This offers a meaningful new option between injections and joint replacement, addressing a critical treatment gap for many patients.

As researchers continue to explore the potential of GAE, this study provides a beacon of hope for millions of knee osteoarthritis sufferers, offering a safe and effective alternative to traditional treatments. The findings not only highlight the procedure’s immediate benefits but also suggest a potential long-term impact on the progression of the disease.